CI: Q2 2026 revenues and earnings surpassed expectations, prompting a raised full-year EPS outlook
Q2 2026 results exceeded expectations, with revenues of $71.7B and adjusted EPS of $7.78. Full-year adjusted EPS outlook was raised to at least $30.45, driven by strong specialty growth, biosimilar adoption, and disciplined execution across segments.Based on The Cigna Group [CI] Q2 2026 Audio Trans…